ArticleBioMed research international2014

Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.

Tomasz Gondek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.